White Paper
THE SCIENTIFIC AI GAP: Why biopharma companies risk falling short of AI goals
Biopharmaceutical leaders aiming to capitalize on artificial intelligence to accelerate new therapeutics and reduce costs frequently struggle with legacy technology dependencies, inefficient custom approaches, and a lack of data harmonization. To bridge this critical scientific AI gap and transform large instrument data volumes into actionable insights, organizations implemented Tetra R&D Data Cloud by TetraScience software. The advanced cloud platform successfully overcame metadata fragmentation by centralizing and harmonizing complex experimental information into analytics-ready formats. By providing a robust foundation for advanced computational models, the software successfully helped biopharma teams enhance operational efficiency, bridge the AI vision-reality divide, and significantly
